Generex Biotechnology Corporation, has entered into a product licensing and distribution agreement with ABP-Comércio, Importação E Exportação Ltda for the registration, importation, marketing, distribution, and sale in Brazil of Glucose RapidSpray.

Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth. Glucose RapidSpray is an innovative alternative for people who want additional glucose in their diet. Glucose RapidSpray delivers a fat-free, low-calorie glucose formulation developed using the Company's proprietary buccal drug delivery technologies. Glucose RapidSpray delivers glucose directly into the buccal cavity and is simple to carry and use.

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs).